Integra Lifesciences Holdings (IART) Raw Materials (2010 - 2017)
Integra Lifesciences Holdings recorded quarterly Raw Materials of $48.4 million in Q3 2017, up 23.2% quarter-over-quarter from $39.2 million in Q4 2016.
Integra Lifesciences Holdings' Raw Materials history runs 7 years deep, the most recent figure standing at $48.4 million for Q3 2017.
- In Q3 2017, Raw Materials changed N/A year-over-year to $48.4 million; the TTM figure through Sep 2017 stood at $48.4 million (changed N/A YoY), while the FY2016 annual figure was $39.2 million, changed N/A from the prior year.
- Raw Materials came in at $48.4 million for Q3 2017 at Integra Lifesciences Holdings, up from $39.2 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $48.4 million in Q3 2017 to a low of $36.5 million in Q4 2014.
- A 4-year average of $41.1 million and a median of $39.7 million in 2015 frame the typical range for Raw Materials.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 48.35 Mn |
| Dec 31, 2016 | 39.25 Mn |
| Jun 30, 2015 | 40.22 Mn |
| Dec 31, 2014 | 36.47 Mn |
| Jun 30, 2012 | 28.40 Mn |
| Mar 31, 2012 | 27.23 Mn |
| Dec 31, 2011 | 28.22 Mn |
| Sep 30, 2011 | 29.69 Mn |
| Jun 30, 2011 | 29.95 Mn |
| Dec 31, 2010 | 27.88 Mn |